Nicolaas Lumen

Long term effects of micro-surgical testicular sperm extraction on androgen status in patients with non obstructive azoospermia.

Phalloplasty: a valuable treatment for males with penile insufficiency.

Salvage intensity-modulated radiotherapy for rising PSA after radical prostatectomy.

Perineal anastomotic urethroplasty for posttraumatic urethral stricture with or without previous urethral manipulations: a review of 61 cases with long-term followup.

Erectile implants in female-to-male transsexuals: our experience in 129 patients.

Urinary toxicity after high dose intensity modulated radiotherapy as primary therapy for prostate cancer.

Hypofractionated intensity-modulated arc therapy for lymph node metastasized prostate cancer.

Adjuvant high-dose intensity-modulated radiotherapy after radical prostatectomy for prostate cancer: clinical results in 104 patients.

Endoscopic incision of short (<3 cm) urethral strictures after phallic reconstruction.

Etiology of urethral stricture disease in the 21st century.

Challenging non-traumatic posterior urethral strictures treated with urethroplasty: a preliminary report.

Urethroplasty for urethral strictures: quality assessment of an in-home algorithm.

Ventral longitudinal stricturotomy and transversal closure: the Heineke-Mikulicz principle in urethroplasty.

Urethroplasty for failed hypospadias repair: a matched cohort analysis.

Urethroplasty for strictures after phallic reconstruction: a single-institution experience.

High-dose salvage intensity-modulated radiotherapy with or without androgen deprivation after radical prostatectomy for rising or persisting prostate-specific antigen: 5-year results.

Population screening for prostate cancer: an overview of available studies and meta-analysis.

Clinical results after high-dose intensity-modulated radiotherapy for high-risk prostate cancer.

Glycosylation of prostate specific antigen and its potential diagnostic applications.

Salvage stereotactic body radiotherapy for patients with limited prostate cancer metastases: deferring androgen deprivation therapy.

Developments in external beam radiotherapy for prostate cancer.

Safe introduction of robot-assisted radical prostatectomy after a training program in a high-volume robotic centre.

Postoperative high-dose pelvic radiotherapy for N+ prostate cancer: toxicity and matched case comparison with postoperative prostate bed-only radiotherapy.

Hypofractionated intensity-modulated arc therapy for lymph node metastasized prostate cancer: early late toxicity and 3-year clinical outcome.

Capillary electrophoresis of urinary prostate glycoproteins assists in the diagnosis of prostate cancer.

Agreement of Gleason score on prostate biopsy and radical prostatectomy specimen: is there improvement with increased number of biopsy cylinders and the 2005 revised Gleason scoring?

Prognostic factors influencing prostate cancer-specific survival in non-castrate patients with metastatic prostate cancer.

A novel design for steerable instruments based on laser-cut nitinol.

Radiotherapy for renal-cell carcinoma.

Contemporary minimally-invasive extended pelvic lymph node dissection for prostate cancer before curative radiotherapy: prospective standardized analysis of complications.

Sequential robot-assisted radical right nephrectomy and cholecystectomy: a safe combined procedure.

Surveillance or metastasis-directed Therapy for OligoMetastatic Prostate cancer recurrence (STOMP): study protocol for a randomized phase II trial.

Urinary prostate protein glycosylation profiling as a diagnostic biomarker for prostate cancer.

Impact of changing rectal dose volume parameters over time on late rectal and urinary toxicity after high-dose intensity-modulated radiotherapy for prostate cancer: A 10-years single centre experience.

Review of the current management of lower urinary tract injuries by the EAU Trauma Guidelines Panel.

Review of the current management of upper urinary tract injuries by the EAU Trauma Guidelines Panel.

Salvage pelvic lymph node dissection in recurrent prostate cancer: surgical and early oncological outcome.

Battling resistance mechanisms in antihormonal prostate cancer treatment: Novel agents and combinations.

Perineal urethrostomy: surgical and functional evaluation of two techniques.

Ablative Intravesical Chemotherapy for Small Recurrent Non-Muscle-Invasive Bladder Cancer: A Prospective Study.

The role of androgen receptor expression in the curative treatment of prostate cancer with radiotherapy: a pilot study.

Two-sided dorsal plus ventral oral graft bulbar urethroplasty: long-term results and predictive factors.

What kind of prostate cancers do we miss on multiparametric magnetic resonance imaging?

Buccal Versus Lingual Mucosa Graft in Anterior Urethroplasty: A Prospective Comparison of Surgical Outcome and Donor Site Morbidity.

Varicocele: the origin of benign prostatic hypertrophy? Testosterone dosages in the periprostatic plexus.

Anastomotic Repair versus Free Graft Urethroplasty for Bulbar Strictures: A Focus on the Impact on Sexual Function.

Diagnostic accuracy of urinary prostate protein glycosylation profiling in prostatitis diagnosis.

Kulkarni Dorsolateral Graft Urethroplasty Using Penile Skin.

Abiraterone acetate post-docetaxel for metastatic castration-resistant prostate cancer in the Belgian compassionate use program.

Duration of urethral catheterization after urethroplasty: how long is enough?

Combining high dose external beam radiotherapy with a simultaneous integrated boost to the dominant intraprostatic lesion: Analysis of genito-urinary and rectal toxicity.

Nontransecting Anastomotic Repair in Urethral Reconstruction: Surgical and Functional Outcomes.

Androgen Receptor Gene Copy Number and Protein Expression in Treatment-Naïve Prostate Cancer.

Whole pelvis radiotherapy for pathological node-positive prostate cancer : Oncological outcome and prognostic factors.

The independent oncological role for cytoreductive nephrectomy in metastatic renal cell carcinoma: Prognostic features in the era of targeted therapies.

Which Factors Predict Overall Survival in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone Acetate Post-Docetaxel?

Release of urinary extracellular vesicles in prostate cancer is associated with altered urinary N-glycosylation profile.

Cytoreductive Prostatectomy for Metastatic Prostate Cancer: First Lessons Learned From the Multicentric Prospective Local Treatment of Metastatic Prostate Cancer (LoMP) Trial.

Neither creatinine- nor cystatin C-estimated glomerular filtration rate is optimal in oncology patients treated with targeted agents.

Author Reply.

Prevalence and prognosis of low-volume, oligorecurrent, hormone-sensitive prostate cancer amenable to lesion ablative therapy.

Grey Areas: Challenges of Developing Guidelines in Adult Urological Trauma.

Outcomes of Early Endoscopic Realignment Versus Suprapubic Cystostomy and Delayed Urethroplasty for Pelvic Fracture-related Posterior Urethral Injuries: A Systematic Review.

Is Nonoperative Management the Best First-line Option for High-grade Renal trauma? A Systematic Review.

Editorial Comment.

Clinical pathway improves implementation of evidence-based strategies for the management of androgen deprivation therapy-induced side effects in men with prostate cancer.

Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial.

Metastatic burden in newly diagnosed hormone-naive metastatic prostate cancer: Comparing definitions of CHAARTED and LATITUDE trial.

Prognostic and Therapeutic Implications of Circulating Androgen Receptor Gene Copy Number in Prostate Cancer Patients Using Droplet Digital Polymerase Chain Reaction.

Single ablative intravesical electromotive mitomycin C administration for small non-muscle-invasive bladder cancer: a prospective study.

4 Weeks Versus 5 Weeks of Hypofractionated High-dose Radiation Therapy as Primary Therapy for Prostate Cancer: Interim Safety Analysis of a Randomized Phase 3 Trial.

Editorial Comment.

Urinary extracellular vesicle biomarkers in urological cancers: From discovery towards clinical implementation.

Pelvic lymph node dissection in prostate cancer staging: evaluation of morbidity and oncological outcomes.

Urethroplasty After Urethral Urolume Stent: An International Multicenter Experience.

Prospective Randomized Controlled Trial Exploring the Effect of TachoSil on Lymphocele Formation After Extended Pelvic Lymph Node Dissection in Prostate Cancer.

Reply to J.-E. Bibault et al, B. Tombal, and C. Cattrini et al.

Validated uroflowmetry-based predictive model for the primary diagnosis of urethral stricture disease in men.

Comparison of the Prostate Imaging Reporting and Data System (PI-RADS) Version 1 and 2 in a Cohort of 245 Patients with Histopathological Reference and Long-Term Follow-Up.

Importance of metastatic volume in prognostic models to predict survival in newly diagnosed metastatic prostate cancer.

Detecting long non-coding RNA biomarkers in prostate cancer liquid biopsies: Hype or hope?

Editorial Comment to Impact of prior local therapy on overall survival in men with metastatic castration-resistant prostate cancer: Results from Shared Equal Access Regional Cancer Hospital.

Patient- versus physician-reported outcomes in prostate cancer patients receiving hypofractionated radiotherapy within a randomized controlled trial.

Abiraterone and spironolactone in prostate cancer: a combination to avoid.

Nodal Oligorecurrent Prostate Cancer: Anatomic Pattern of Possible Treatment Failure in Relation to Elective Surgical and Radiotherapy Treatment Templates.

Benefits of Elective Para-Aortic Radiotherapy for pN1 Prostate Cancer Using Arc Therapy (Intensity-Modulated or Volumetric Modulated Arc Therapy): Protocol for a Nonrandomized Phase II Trial.

Discovery and validation of a serum microRNA signature to characterize oligo- and polymetastatic prostate cancer: not ready for prime time.

Urethroplasty for urethral injuries and trauma-related strictures in children and adolescents: a single-institution experience.

Articulated Instruments and 3D Visualization: A Synergy? Evaluation of Execution Time, Errors, and Visual Fatigue.

Neo-vaginal Advancement Flaps in the Treatment of Urethral Strictures in Transwomen.

Current Management of pT3b Prostate Cancer After Robot-assisted Laparoscopic Prostatectomy.

N-Linked Glycosylation and Near-Infrared Spectroscopy in the Diagnosis of Prostate Cancer.

Which clinical and radiological characteristics can predict clinically significant prostate cancer in PI-RADS 3 lesions? A retrospective study in a high-volume academic center.

Radiation Dosimetry and Biodistribution of F-PSMA-11 for PET Imaging of Prostate Cancer.

Robot-assisted nephroureterectomy for upper tract urothelial carcinoma: results from three high-volume robotic surgery institutions.

Hyperbaric oxygen therapy for radiation cystitis after pelvic radiotherapy: Systematic review of the recent literature.

A Trial-Based Cost-Utility Analysis of Metastasis-Directed Therapy for Oligorecurrent Prostate Cancer.

European Association of Urology Guidelines Office: How We Ensure Transparent Conflict of Interest Disclosure and Management.

Perineal Urethrostomy for Complicated Anterior Urethral Strictures: Indications and Patient's Choice. An Analysis at a Single Institution.

Exercise prescription dose for castrate-resistant prostate cancer patients: a phase I prescription dose escalation trial.

Primary versus Redo Urethroplasty: Results from a Single-Center Comparative Analysis.

Independent risk factors for failure after anterior urethroplasty: a multivariate analysis on prospective data.

Advances in Urogenital Trauma and Reconstruction.

AUTHOR REPLY.

Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine.

Excision and Primary Anastomosis for Isolated, Short, Anastomotic Strictures in Transmen.

European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 Era.

Real-World Outcomes in First-Line Treatment of Metastatic Castration-Resistant Prostate Cancer: The Prostate Cancer Registry.

Phalloplasty in biological men with penile insufficiency.

Urethroplasty for Failed Hypospadias Repair Related Strictures in Adults: A Retrospective Analysis With Long-term Follow-up.

Surgical repair of urethral complications after metoidioplasty for genital gender affirming surgery.

VeSpAR trial: a randomized controlled trial comparing vessel-sparing anastomotic repair and transecting anastomotic repair in isolated short bulbar urethral strictures.

Preparation of Multi-omics Grade Extracellular Vesicles by Density-Based Fractionation of Urine.

IMAGINE-IMpact Assessment of Guidelines Implementation and Education: The Next Frontier for Harmonising Urological Practice Across Europe by Improving Adherence to Guidelines.

Phalloplasty in cis-men with penile insufficiency: evaluation of outcomes and surgical complications : Good ability to achieve orgasm, high urinary complication rate.

Implantation of the ZSI 475 FTM Erectile Device After Phalloplasty: A Prospective Analysis of Surgical Outcomes.

Tissue linked glycosylation as potential prognostic biomarker for biochemical recurrence-free survival.

Real-World Safety and Efficacy Outcomes with Abiraterone Acetate Plus Prednisone or Prednisolone as the First- or Second-Line Treatment for Metastatic Castration-Resistant Prostate Cancer: Data from the Prostate Cancer Registry.

Update on the management of complex strictures of the bulbar urethra.

Urethral Complications After Metoidioplasty for Genital Gender Affirming Surgery.

Multicentre, prospective study on local treatment of metastatic prostate cancer (LoMP study).

The Role of Cytoreductive Radical Prostatectomy in the Treatment of Newly Diagnosed Low-volume Metastatic Prostate Cancer. Results from the Local Treatment of Metastatic Prostate Cancer (LoMP) Registry.

Dexamethasone use in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate: this "cort" is not out of order!

Treatment of Urethral Strictures in Transmasculine Patients.

Female Urethroplasty: Outcomes of Different Techniques in a Single Center.

Treatment of Meatal Strictures by Dorsal Inlay Oral Mucosa Graft Urethroplasty: A Single-Center Experience.

Devastated Bladder Outlet in Pelvic Cancer Survivors: Issues on Surgical Reconstruction and Quality of Life.

Tissue- and Blood-derived Genomic Biomarkers for Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review.

Surgical Outcomes After Treatment of Urethral Complications Following Metoidioplasty in Transgender Men.

POIROT trial: post-operative imaging after urethroplasty with peri-catheter retrograde urethrography or trial of voiding with voiding cysto-urethrography.

Impact of F-PSMA-11 PET/CT on Management of Biochemical Recurrence and High-Risk Prostate Cancer Staging : F-PSMA-11 PET/CT and Impact on Prostate Cancer Management.

Genomic Features of Lung-Recurrent Hormone-Sensitive Prostate Cancer.